Low Dose Naltrexone (LDN) is being explored as a potential treatment for Inflammatory Bowel Disease (IBD). It may help by modulating the immune system, reducing inflammation, and providing pain relief. However, its use in IBD is considered experimental and not widely accepted within the medical community.
